ライフサイエンスコーパス: suppressor cell

1 -DC, DC-10, and PGE2-induced myeloid-derived suppressor cells.

2 d granulocytic and monocytic myeloid-derived suppressor cells.

3 ne suppressive activities of myeloid-derived suppressor cells.

4 to induce the generation of CD8(+)CD28(-) T suppressor cells.

5 ressed on tumor infiltrating myeloid-derived suppressor cells.

6 (+) macrophages and Ly-6C(+) myeloid-derived suppressor cells.

7 gest that these cells may be myeloid derived suppressor cells.

8 effects by the elimination of CD38(+) immune-suppressor cells.

9 asing regulatory T cells and myeloid-derived suppressor cells.

10 ored more M2 macrophages and myeloid-derived suppressor cells.

11 associated with expansion of myeloid-derived suppressor cells.

12 egulatory, B regulatory, and myeloid-derived suppressor cells.

13 on of T regulatory cells and myeloid-derived suppressor cells.

14 lls, regulatory T cells, and myeloid-derived suppressor cells.

15 severely depressed numbers of lung CD8(+) T suppressor cells.

16 aematopoietic progenitor and myeloid-derived suppressor cells.

17 r-associated fibroblasts and myeloid-derived suppressor cells.

18 se cells belong to monocytic myeloid-derived suppressor cells.

19 tumor-infiltrating Treg and myeloid-derived suppressor cells.

20 iggering the accumulation of myeloid-derived suppressor cells.

21 ch could be characterized as myeloid-derived suppressor cells.

22 leukemias and production of myeloid-derived suppressor cells.

23 l killer cells and decreased myeloid-derived suppressor cells.

24 yeloid cells into functional myeloid-derived suppressor cells.

25 trophils (LDNs)/granulocytic myeloid-derived suppressor cells.

26 Myeloid-derived suppressor cells, a group of immature neutrophils recent

27 owever, in vivo depletion of myeloid-derived suppressor cells abrogated both Treg expansion and prote

28 innate immunity and impaired myeloid-derived suppressor cell activation.

29 enograft assays to establish that the tumour suppressor Cell adhesion molecule 1 (CADM1) inhibits SqC

30 Depletion of neutrophils/myeloid-derived suppressor cells also suppressed metastasis suggesting a

31 for subsequent expansion of myeloid-derived suppressor cells and for promoting their immunomodulator

32 acterized by an abundance of myeloid-derived suppressor cells and inhibition of cytotoxic T-cell infi

33 onsequence, the frequency of myeloid-derived suppressor cells and its ratio to CD8(+) T cells increas

34 ecruitment of both monocytic myeloid-derived suppressor cells and macrophages, thereby promoting meta

35 CL3, which binds to CXCR2 on myeloid-derived suppressor cells and promotes their migration to the tum

36 by cell populations such as myeloid-derived suppressor cells and regulatory T cells, as well as immu

37 ressive cell subsets such as myeloid-derived suppressor cells and regulatory T cells.

38 gulatory mediators TGF-beta, myeloid-derived suppressor cells and regulatory T-cells.

39 LC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour growth.

40 e number of granulocyte-like myeloid-derived suppressor cells (and their expression of programmed-dea

41 +) T cells and CD11(+)Gr1(+) myeloid-derived suppressor cells, and changes in the chemokine/cytokine

42 ells, innate lymphoid cells, myeloid-derived suppressor cells, and natural killer cells) as well as a

43 cells, type II macrophages, myeloid-derived suppressor cells, and other immunosuppressive cells that

44 macrophages and granulocytic myeloid-derived suppressor cells, and protumor T-regulatory/Th17 cell re

45 crophages, Langerhans cells, myeloid-derived suppressor cells, and regulatory T and B lymphocytes.

46 n, and expansion of immature myeloid-derived suppressor cells are all contributory.

47 honuclear cells/granulocytic myeloid-derived suppressor cells are due to the loss of CD44 upon enzyma

48 Myeloid-derived suppressor cells are known to impair immune cell functio

49 inflammatory response and/or myeloid-derived suppressor cells are neutralized.

50 r-associated macrophages and myeloid-derived suppressor cells, are abundant in the HCC microenvironme

51 xpansion of Gr-1(+) CD11b(+) myeloid-derived suppressor cells, as well as elevated levels of immune a

52 ich are rapidly exploited as myeloid-derived suppressor cells at the cost of tumor-reactive lymphoid

53 tion of CD11b+Gr1intF4/80int myeloid-derived suppressor cells at the resection margin and increased t

54 predominantly in neutrophil/myeloid-derived suppressor cells, but rarely in tumor cells.

55 mediated by M2 macrophages, myeloid-derived suppressor cells, CD1d(hi)CD5(+) regulatory B cells, and

56 in cargo of exosomes shed by myeloid-derived suppressor cells collected under high and low conditions

57 ted increased recruitment of myeloid-derived suppressor cells, consistent with protection of the epit

58 uding regulatory T cells and myeloid-derived suppressor cells, correlating with an increased therapeu

59 olecular patterns expands BM myeloid-derived suppressor cells, creating a feed-forward process propag

60 tivation of AKT, activation of the p53 tumor suppressor cell cycle checkpoint and cell death.

61 ater numbers of macrophages, myeloid-derived suppressor cells, dendritic cells, and granulocytes than

62 indicate that denileukin diftitox and other suppressor cell-depleting therapies may be useful adjunc

63 macrophage polarization and myeloid-derived suppressor cell differentiation, respectively, most like

64 ent may, thus, limit desmoplasia and myeloid suppressor cell differentiation.

65 f phenformin on granulocytic myeloid-derived suppressor cell-driven immune suppression and support th

66 epletion of T-regulatory and myeloid-derived suppressor cells during TB infection.

67 s document the generation of myeloid-derived suppressor cells during TB, suggesting their role in TB

68 Foxp3+ regulatory T cells (Tregs) are potent suppressor cells, essential for the maintenance of immun

69 cell (DC) differentiation to myeloid-derived suppressor cell expansion during tumour progression.

70 d to the finding that alloantigen-specific T suppressor cells express IL-2 receptor (CD25) and that I

71 lly and functionally, to the myeloid-derived suppressor cells found in cancer because they exerted a

72 henotypically similar to the myeloid-derived suppressor cells found in patients with cancer, have rec

73 LDN/granulocytic myeloid-derived suppressor cell frequency in CVID patients correlated wi

74 Depletion of myeloid-derived suppressor cells from post-cardiopulmonary bypass periph

75 Granulocytic myeloid-derived suppressor cells (G-MDSCs) promote tumor growth and immu

76 ry emergence of granulocytic myeloid-derived suppressor cells (G-MDSCs) that mediated immune escape b

77 suppressor macrophages, and myeloid-derived suppressor cells, generated in vitro from the same mouse

78 reg), Th17, and granulocytic myeloid-derived suppressor cells (gMDSC) were increased significantly in

79 ow-median baseline levels of myeloid-derived suppressor cells had prolonged OS compared with their co

80 Antibiotics up-regulated the myeloid-derived suppressor cells, immature myeloid progenitor cells know

81 equency of immunosuppressive myeloid-derived suppressor cells in a syngeneic TNBC mouse model.

82 s, the phenotype typical for myeloid-derived suppressor cells in cancer or immature myeloid cells (IM

83 und they differentiated into myeloid-derived suppressor cells in early metastatic sites of tumor-bear

84 tively inhibits granulocytic myeloid-derived suppressor cells in spleens of tumor-bearing mice and ex

85 revealed the accumulation of myeloid-derived suppressor cells in the lung and liver.

86 only reduced tumor-promoting myeloid-derived suppressor cells in the lung, but also down-regulated th

87 ficiency, which also lessens myeloid-derived suppressor cells in the premetastatic niche, synergized

88 neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvironment.

89 ercentage of macrophages and myeloid-derived suppressor cells in the tumor microenvironment.

90 r associated macrophages and myeloid derived suppressor cells in the tumor microenvironment.

91 ines, including TGF-beta, by myeloid-derived suppressor cells in tumor-draining lymph nodes, leading

92 ay inhibition and to inhibit myeloid-derived suppressor cells in various melanoma models.

93 (+) regulatory T cells are well-known immune suppressor cells in various settings.

94 These myeloid-derived suppressor cells induce an immunosuppressive T cell phen

95 nulocytic (gMDSC) subsets of myeloid-derived suppressor cells infiltrate in the primary tumour and di

96 ell killing while decreasing myeloid-derived suppressor cell infiltration and IL10 production in the

97 splenic proliferation of bone marrow-derived suppressor cells, inhibiting the adaptive immune respons

98 differentiation of monocytic myeloid-derived suppressor cells into highly immunosuppressive M2-polari

99 es in the differentiation of myeloid-derived suppressor cells into macrophages, which governs maligna

100 ch as regulatory T cells and myeloid-derived suppressor cells, into the tumour microenvironment.

101 neutrophils (or granulocytic myeloid-derived suppressor cells), is resistant to ICB, and contains a m

102 y a balanced distribution of myeloid-derived suppressor cell-like and APC-like myeloid phenotypes and

103 Myeloid-derived suppressor cell-like fibrocytes were increased in COPD c

104 to the apparent expansion of myeloid-derived suppressor cell-like populations.

105 e monocytic and granulocytic myeloid-derived suppressor cells (M- and G-MDSCs) defined by their abili

106 arly recruitment of monocyte-myeloid-derived suppressor cells (M-MDSCs) and neutrophils that actively

107 in turn, activate monocytic myeloid-derived suppressor cells (M-MDSCs) via IL-13 secretion.

108 trophils, T cells, monocytic myeloid-derived suppressor cells (M-MDSCs), and group 2 innate lymphoid

109 lls (PMN-MDSCs), mononuclear myeloid-derived suppressor cells (M-MDSCs), and Lox-1(+) PMN-MDSCs in pe

110 les in innate cells, such as myeloid-derived suppressor cells, macrophages, and dendritic cells, sugg

111 myeloid cells expressing the myeloid-derived suppressor cell marker S100A9 only in a TN breast cancer

112 ociated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) infiltration in tumors via chemok

113 The myeloid-derived suppressor cell (MDSC) is the 'queen bee' of the tumor m

114 tomach, where they exhibited myeloid-derived suppressor cell (MDSC) markers and acquired the ability

115 icroenvironment by promoting myeloid-derived suppressor cell (MDSC) proliferation and activation.

116 s) and (ii) CD45(+) CD34(-) [myeloid-derived suppressor cell (MDSC)-like fibrocytes] cells in stable

117 d medium differentiated into myeloid derived suppressor cells (MDSC) (CD33(+)CD11b(+)HLA-DR(-/low)).

118 ve an increased frequency of myeloid derived suppressor cells (MDSC) and are at increased risk for ca

119 to mobilization of immature myeloid-derived suppressor cells (MDSC) and enhancing their production o

120 umulation of lung-associated myeloid-derived suppressor cells (MDSC) and MDSC-derived production of T

121 wherein the accumulation of myeloid-derived suppressor cells (MDSC) and regulatory T cells in colon

122 immunosuppressive cells are myeloid-derived suppressor cells (MDSC) and tumor-associated macrophages

123 The increased presence of myeloid-derived suppressor cells (MDSC) and tumor-associated macrophages

124 Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of imm

125 Myeloid-derived suppressor cells (MDSC) are a heterogeneous population o

126 Myeloid-derived suppressor cells (MDSC) are a major obstacle to promisin

127 Myeloid-derived suppressor cells (MDSC) are an immunosuppressive populat

128 Myeloid-derived suppressor cells (MDSC) are elevated in most individuals

129 t of this, T-cell inhibitory myeloid-derived suppressor cells (MDSC) are gaining interest as key faci

130 Myeloid-derived suppressor cells (MDSC) are one of the major negative re

131 Regulation of myeloid-derived suppressor cells (MDSC) by ongoing inflammation followin

132 Myeloid-derived suppressor cells (MDSC) contribute significantly to the

133 Myeloid-derived suppressor cells (MDSC) contribute to an immunosuppressi

134 Tumor-induced myeloid-derived suppressor cells (MDSC) contribute to immune suppression

135 Myeloid-derived suppressor cells (MDSC) contribute to immune suppression

136 cells allowed generation of myeloid-derived suppressor cells (MDSC) from precursors in mouse bone ma

137 Traditionally, myeloid-derived suppressor cells (MDSC) have been studied in regard to t

138 (CD11b(+)Ly6G(-)Ly6C(high)) myeloid-derived suppressor cells (MDSC) in chronically infected mice, wh

139 Accumulation of myeloid-derived suppressor cells (MDSC) in melanoma microenvironment is

140 st, it reduced the levels of myeloid-derived suppressor cells (MDSC) in mice bearing Lewis lung carci

141 induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC) in the peritoneum, which express

142 Our data suggest that myeloid-derived suppressor cells (MDSC) in the TME are a major source of

143 sociated with restoration of myeloid-derived suppressor cells (MDSC) in the tumor microenvironment, i

144 Myeloid-derived suppressor cells (MDSC) include immature monocytic (M-MD

145 cy may be the recruitment of myeloid-derived suppressor cells (MDSC) into the tumor microenvironment.

146 Although accumulation of myeloid-derived suppressor cells (MDSC) is a hallmark of cancer, the und

147 Inhibiting myeloid-derived suppressor cells (MDSC) might be the ultimate barrier to

148 Myeloid derived suppressor cells (MDSC) produce nitric oxide (NO) and in

149 Myeloid-derived suppressor cells (MDSC) promote colorectal cancer by sev

150 Myeloid-derived suppressor cells (MDSC) represent a primary mechanism of

151 Myeloid-derived suppressor cells (MDSC) represent a unique cell populati

152 Immunosuppressive myeloid-derived suppressor cells (MDSC) subvert antitumor immunity and l

153 sue recruited CXCR2-positive myeloid-derived suppressor cells (MDSC) to form a premetastatic niche th

154 mobilization of granulocytic myeloid-derived suppressor cells (MDSC) to the breast cancer lung metast

155 clitaxel to tumor-associated myeloid-derived suppressor cells (MDSC), (ii) MPO-regulated release, and

156 n, including FoxP3(+) Tregs, myeloid-derived suppressor cells (MDSC), and M2 macrophages.

157 immunosuppressive cytokines, myeloid-derived suppressor cells (MDSC), and regulatory T cells (Treg).

158 mune suppression mediated by myeloid-derived suppressor cells (MDSC), as derived from cytokine induct

159 rt normal myeloid cells into myeloid-derived suppressor cells (MDSC), inhibiting antitumor immune res

160 ave previously reported that myeloid-derived suppressor cells (MDSC), which are a heterogeneous popul

161 Myeloid-derived suppressor cells (MDSC), which expand during states of e

162 ry T cells (Treg) and innate myeloid-derived suppressor cells (MDSC), which facilitate immune escape

163 expression is a hallmark of myeloid-derived suppressor cells (MDSC).

164 egulatory T cells (Treg) and myeloid-derived suppressor cells (MDSC).

165 nase activity, identified as myeloid-derived suppressor cells (MDSC).

166 ociated macrophages (TAM) or myeloid-derived suppressor cells (MDSC).

167 by inducing accumulation of myeloid-derived suppressor cells (MDSC).

168 d to induce the expansion of myeloid-derived suppressor cells (MDSC); however, little is known regard

169 pressive immune populations (myeloid-derived suppressor cells; MDSC) compared to control diet fed mic

170 Myeloid-derived suppressor cells (MDSCs) accumulate as a result of infla

171 ncreased in myeloid cells as myeloid-derived suppressor cells (MDSCs) accumulated, which was associat

172 ingly, a subset of monocytic myeloid-derived suppressor cells (MDSCs) also expressed CD2 and CREMalph

173 Recruitment of monocytic myeloid-derived suppressor cells (MDSCs) and differentiation of tumor-as

174 umor infiltration, decreased myeloid-derived suppressor cells (MDSCs) and further decreased circulati

175 lammatory cells that include myeloid-derived suppressor cells (MDSCs) and IL-13(+) Th2 cells.

176 ive monocyte polarization to myeloid-derived suppressor cells (MDSCs) and M2-like macrophages.

177 latory mechanism mediated by myeloid-derived suppressor cells (MDSCs) and showed that MDSCs expanded

178 as phenotypically similar to myeloid-derived suppressor cells (MDSCs) and that suppressed T cell resp

179 ion of myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophage

180 Myeloid-derived suppressor cells (MDSCs) are a group of heterogeneous ce

181 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population

182 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population

183 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population

184 Myeloid-derived suppressor cells (MDSCs) are a naturally occurring immun

185 cancer metastasis, in which myeloid-derived suppressor cells (MDSCs) are an important participant.

186 Myeloid-derived suppressor cells (MDSCs) are greatly expanded in cancer

187 Myeloid-derived suppressor cells (MDSCs) are highly prevalent inflammato

188 Myeloid-derived suppressor cells (MDSCs) are immature suppressive cells

189 Myeloid-derived suppressor cells (MDSCs) are immune cells that exert imm

190 Myeloid-derived suppressor cells (MDSCs) are immunosuppressive cells tha

191 Myeloid-derived suppressor cells (MDSCs) are innate immune cells that me

192 Myeloid-derived suppressor cells (MDSCs) are key players in immune evasi

193 Myeloid-derived suppressor cells (MDSCs) are key regulatory cells that c

194 Myeloid-derived suppressor cells (MDSCs) are known to play important rol

195 Myeloid-derived suppressor cells (MDSCs) are major regulators of T cell

196 As myeloid-derived suppressor cells (MDSCs) are potent immunoregulatory cel

197 Myeloid progenitor-derived suppressor cells (MDSCs) arise from myeloid progenitors

198 essive microenvironment with myeloid-derived suppressor cells (MDSCs) as a dominant population.

199 ont in cancer research, with myeloid-derived suppressor cells (MDSCs) as a main oncology immunotherap

200 lls and fewer Gr1(+)CD11b(+) myeloid-derived suppressor cells (MDSCs) at early time points following

201 ntiation and accumulation of myeloid-derived suppressor cells (MDSCs) both in vitro and in vivo.

202 Myeloid-derived suppressor cells (MDSCs) can promote tumor progression.

203 Myeloid-derived suppressor cells (MDSCs) constitute a key checkpoint tha

204 The systemic accumulation of myeloid-derived suppressor cells (MDSCs) decreased significantly in flox

205 Myeloid-derived suppressor cells (MDSCs) described in cancer and inflamm

206 investigated the response of myeloid-derived suppressor cells (MDSCs) during the pathogenesis of an i

207 Myeloid-derived suppressor cells (MDSCs) expand in an inflammatory micro

208 CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) expand in the spleen during can

209 eutrophils, and granulocytic myeloid-derived suppressor cells (MDSCs) from cancer patients extrude th

210 The accumulation of myeloid-derived suppressor cells (MDSCs) has been observed in solid tumo

211 Myeloid-derived suppressor cells (MDSCs) have emerged as major regulator

212 understanding of the role of myeloid-derived suppressor cells (MDSCs) in cancer is becoming increasin

213 entified a critical role for myeloid-derived suppressor cells (MDSCs) in S. aureus biofilm persistenc

214 work demonstrated a role for myeloid-derived suppressor cells (MDSCs) in the antimicrobial response i

215 The role of myeloid-derived suppressor cells (MDSCs) in the graft protection provide

216 t al show the involvement of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of immune t

217 owed massive mobilization of myeloid-derived suppressor cells (MDSCs) in the peritoneal cavity.

218 y influences the function of myeloid-derived suppressor cells (MDSCs) in the setting of acute graft-v

219 Myeloid-derived suppressor cells (MDSCs) increase in patients with cance

220 In cancer, increased myeloid-derived suppressor cells (MDSCs) induce detrimental immunosuppre

221 immune-suppressive activity, myeloid-derived suppressor cells (MDSCs) influence tumor progression in

222 Myeloid-derived suppressor cells (MDSCs) inhibit T-cell expansion and fu

223 n tumor microenvironments by myeloid-derived suppressor cells (MDSCs) is widely accepted.

224 cells, accumulation of donor myeloid-derived suppressor cells (MDSCs) mediated by ILC2 production of

225 Myeloid-derived suppressor cells (MDSCs) play a critical role in promoti

226 Myeloid-derived suppressor cells (MDSCs) play a major role in cancer.

227 of immunosuppressive CD33(+) myeloid-derived suppressor cells (MDSCs) that negatively correlated with

228 vestigated the potential for myeloid-derived suppressor cells (MDSCs) to suppress T cell-mediated imm

229 1(high)Ly-6C(+) granulocytic myeloid-derived suppressor cells (MDSCs) to the liver of HLA-DR4 transge

230 DCs and Gr-1(high)CD11c(neg) myeloid-derived suppressor cells (MDSCs) were enriched in GVHD target or

231 Myeloid-derived suppressor cells (MDSCs) were recently found to accumula

232 restingly, immunosuppressive myeloid-derived suppressor cells (MDSCs) were recruited to tumor tissue

233 y decrease the population of myeloid derived suppressor cells (MDSCs) within the tumor microenvironme

234 s have previously shown that myeloid-derived suppressor cells (MDSCs), a heterogeneous population of

235 Myeloid-derived suppressor cells (MDSCs), a subset of immunosuppressive

236 ry (TRM) CD8+ T lymphocytes, myeloid-derived suppressor cells (MDSCs), and alternatively activated M2

237 Myeloid-Derived Suppressor Cells (MDSCs), immunosuppressive cells that p

238 nally resemble tumor-induced myeloid-derived suppressor cells (MDSCs), indicating an essential role o

239 population of stromal cells, myeloid-derived suppressor cells (MDSCs), is present in tumors.

240 yeloid immune cells, such as myeloid-derived suppressor cells (MDSCs), populate inflamed or cancerous

241 immune-inhibitory responses (myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), an

242 and massive accumulation of myeloid-derived suppressor cells (MDSCs), which actively suppressed anti

243 tinct subset of neutrophilic myeloid-derived suppressor cells (MDSCs), which functionally suppress T

244 at failed to induce IL-10 in myeloid-derived suppressor cells (MDSCs), which identified a critical ro

245 immature populations termed myeloid-derived suppressor cells (MDSCs).

246 ociated with the decrease of myeloid-derived suppressor cells (MDSCs).

247 eneration and recruitment of myeloid-derived suppressor cells (MDSCs).

248 ture myeloid cells, known as myeloid-derived suppressor cells (MDSCs).

249 icating that these cells are myeloid-derived suppressor cells (MDSCs).

250 These are characteristics of myeloid-derived suppressor cells (MDSCs).

251 T-effector cells and reduced myeloid-derived suppressor cells (MDSCs).

252 which drives mobilization of myeloid-derived suppressor cells (MDSCs).

253 ough its selective effect on myeloid-derived suppressor cells (MDSCs).

254 accompanied by an influx of myeloid derived suppressor cells (MDSCs).

255 y every cell type, including myeloid-derived suppressor cells (MDSCs).

256 trated from the circulation (myeloid-derived suppressor cells [MDSCs], monocyte-derived macrophages [

257 Myeloid-derived suppressor cell-mediated immunosuppression can be antige

258 8.35; P = .01) and monocytic myeloid derived suppressor cells (mMDSC) (95% CI, 3.62-12.74; P = .001)

259 Monocytic myeloid-derived suppressor cells (mMDSC) are an important component of t

260 riven expansion of monocytic myeloid-derived suppressor cells (mMDSC) from human or mouse myeloid pro

261 creased numbers of monocytic myeloid-derived suppressor cells (Mo-MDSC) in psoriasis patients and exa

262 4(+) HLA-DR(-/low) monocytic myeloid-derived suppressor cells (Mo-MDSCs) have been shown to suppress

263 Human monocytic myeloid-derived suppressor cells (MO-MDSCs) within the hepatic compartme

264 cells, natural killer cells, myeloid-derived suppressor cells, neutrophils, or macrophages.

265 f inflammatory cytokines and myeloid-derived suppressor cells occurs in patients with coronavirus dis

266 their murine counterparts, are highly potent suppressor cells of both CD4(+) and CD8(+) T cell respon

267 to generate ex vivo a subpopulation of human suppressor cells of monocytic origin, referred to as hum

268 Regulatory T-cells, natural suppressor cells of the immune system, control pro-infla

269 umor-associated macrophages, myeloid-derived suppressor cells, or inflammatory monocytes, functions o

270 gs) (ie, ICOShigh/PD-1-) and myeloid-derived suppressor cells (PD-1low) are expanded in cases with TP

271 Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activate

272 recruitment of granulocytic myeloid-derived suppressor cells (PMN-MDSCs) into tumor tissues, thereby

273 NK) cells, polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), mononuclear myeloid-derive

274 polymorphonuclear neutrophil myeloid-derived suppressor cells (PMN-MDSCs).

275 ce demonstrated expansion of myeloid-derived suppressor cell populations and sustained weight loss fo

276 Regulatory B cells and myeloid-derived suppressor cells, previously shown to express CD38, were

277 atory T cell recruitment and myeloid-derived suppressor cell proliferation.

278 cantly modulate intratumoral myeloid-derived suppressor cells quantitatively, but diminished their su

279 hing appears to be caused by myeloid-derived suppressor cells recruited to the premetastatic lungs th

280 ammaR-dependent mechanism regulates CD8(+) T suppressor cell recruitment, limits immunopathogenesis,

281 high levels of granulocytic myeloid-derived suppressor cells resulted in loss of immunotherapeutic p

282 cell death pathways, we found the monocytic suppressor-cell subset, but not the granulocytic subset,

283 s immune factors involved in myeloid-derived suppressor cell survival and trafficking.

284 CD4 T suppressor cells that ex vivo reverted to effector cells

285 ead favored the induction of myeloid-derived suppressor cells, the immune-suppressive interleukin-10

286 This system employed an ion suppressor cell to desalt the chromatographic effluent o

287 ctional plasticity and can be converted from suppressor cells to pathogenic effector cells, enhancing

288 recruitment of monocytes and myeloid-derived suppressor cells to the tumor microenvironment.

289 ession by driving differentiation of myeloid suppressor cells together with TGF-beta.

290 actions of tumor-associated myeloid-derived suppressor cells (tumor-MDSCs).

291 er, significant expansion of myeloid-derived suppressor cells was detected in the recipients of CD47-

292 CBD-induced suppressor cells were comprised of CD11b(+)Ly6-G(+)Ly6-C

293 Intratumoral myeloid-derived suppressor cells were decreased by the combined treatmen

294 ns of T-regulatory cells and myeloid-derived suppressor cells were observed in both rejection and tol

295 ygen species in granulocytic myeloid-derived suppressor cells, whereas the antioxidant N-acetylcystei

296 oration and were enriched in myeloid-derived suppressor cells which could be responsible for immunosu

297 We found that myeloid-derived suppressor cells, which are elevated in the course of ch

298 aling responses in monocytic myeloid-derived suppressor cells, which was paired with their pronounced

299 effector T cells, Tregs, and myeloid-derived suppressor cells, while effector T cells expressed more

300 revealed a subpopulation of myeloid-derived suppressor cells within the CD11b(+) Gr-1(high) cell fra